KALV - KalVista Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue16,1278,3941,5042,133
Cost of Revenue35,02118,23712,66614,661
Gross Profit-18,894-9,843-11,162-12,528
Operating Expenses
Research Development----
Selling General and Administrative10,9268,86211,1772,653
Non Recurring----
Total Operating Expenses45,94727,09923,84317,314
Operating Income or Loss-29,820-18,705-22,339-15,181
Income from Continuing Operations
Total Other Income/Expenses Net9,1282,9003,7363,745
Earnings Before Interest and Taxes-29,820-18,705-22,339-15,181
Interest Expense----
Income Before Tax-20,692-15,805-18,603-11,436
Income Tax Expense124---
Minority Interest----
Net Income From Continuing Ops-20,816-15,805-18,603-11,436
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-20,816-15,805-18,603-11,436
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-20,816-15,805-20,775-15,475